Valeant Pharma To Buy OraPharma - Quick Facts

Valeant Pharmaceuticals International (VRX) Is Losing Ground On Offering News

Valeant To Raise About $1.75 Bln Through Share Offering

Valeant Pharma To Present At Goldman Sachs Conference; Webcast At 12:20 PM ET

Valeant Pharmaceuticals International (VRX) Rose To A New High After Acquisition

Trade VRX now with

6/15/2012 8:08 AM ET

Valeant Pharmaceuticals International Inc. (VRX: Quote,VRX.TO: Quote) has agreed to acquire OraPharma, a specialty oral health company, from Water Street Healthcare Partners, a private equity firm focused exclusively on the health care industry. Total consideration is around $312 million and up to $114 million in potential contingent payments based on certain milestones, including revenue targets.

OraPharma's lead product is Arestin, a locally administered antibiotic for the treatment of periodontitis that utilizes an advanced controlled-release delivery system and is indicated for use in conjunction with scaling and root planing for the treatment of adult periodontitis. As of March 31, 2012, OraPharma's trailing 12-month net revenue was some $95 million with the business growing at a high single digit rate.

The transaction, which may close in June 2012, is expected to be accretive in 2012.

Click here to receive FREE breaking news email alerts for Valeant Pharmaceuticals International and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 64 Articles Next>>

Editors Pick

King Makes Last Plea For Stimulus Before Entrusting BoE To Carney's 'Safe Hands'

Bank of England Governor Mervyn King made a last but strong call for expanding stimulus for the British economy in his final Mansion House speech on Wednesday even as he left some "unfinished business" in the banking sector for the next chief Mark Carney to complete. King will step down by end-June after ten years at the helm. Carney will assume office from July 1.

Red Hat Results Edge Past Estimates

Red Hat Inc., the world's largest seller of Linux software, said Wednesday after the markets closed that its first quarter profit rose 8% from last year, as revenue increased 15% amid strong consumer demand. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue.

Negative Reaction To Fed Leads To Sell-Off On Wall Street - U.S. Commentary

After moving mostly higher over the course of the two previous sessions, stocks pulled back sharply during trading on Wednesday. A negative reaction to the Federal Reserve's monetary policy announcement weighed on the markets in afternoon trading. The major averages saw some volatility following the announcement from the Fed, closing firmly in the red.